Nodlin: Phase I start

Next month, Shanghai Biolaxy Medical Science & Technology Co. Ltd. will begin an open-label, Chinese Phase I trial to evaluate oral Nodlin in up to 26 healthy volunteers. Shanghai Biolaxy is a subsidi...